ClinicalTrials.gov
ClinicalTrials.gov Menu

Omega-3 Fatty Acids and Health Effects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01034423
Recruitment Status : Completed
First Posted : December 17, 2009
Last Update Posted : February 4, 2015
Sponsor:
Information provided by (Responsible Party):
Stine Marie Ulven, Oslo and Akershus University College of Applied Sciences

Brief Summary:
The investigators want to study health effects from omega-3 fatty acids, from fishoil with different quality.

Condition or disease Intervention/treatment Phase
Healthy Dietary Supplement: Omega-3 Dietary Supplement: sun flower oil Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 69 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: Omega-3 Fatty Acids and Health Effects
Study Start Date : September 2009
Actual Primary Completion Date : December 2009
Actual Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: omega-3 high quality Dietary Supplement: Omega-3
Capsules with omega-3 fatty acids.
Dietary Supplement: sun flower oil
Capsules with sun flower oil.
Experimental: omega-3 low quality Dietary Supplement: Omega-3
Capsules with omega-3 fatty acids.
Dietary Supplement: sun flower oil
Capsules with sun flower oil.
Placebo Comparator: placebo Dietary Supplement: Omega-3
Capsules with omega-3 fatty acids.
Dietary Supplement: sun flower oil
Capsules with sun flower oil.



Primary Outcome Measures :
  1. Primary and secondary oxidation products [ Time Frame: baseline (0 weeks), 3 weeks and 7 weeks ]

Secondary Outcome Measures :
  1. inflammatory markers [ Time Frame: after 0,3 and 7 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy individuals.

Exclusion Criteria:

  • Pregnant women, lactating women, chronic diseases and smoking.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01034423


Sponsors and Collaborators
Oslo and Akershus University College of Applied Sciences
Investigators
Study Chair: Stine M Ulven, PhD Oslo and Akershus University College of Applied Sciences

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Stine Marie Ulven, Associate Professor, Oslo and Akershus University College of Applied Sciences
ClinicalTrials.gov Identifier: NCT01034423     History of Changes
Other Study ID Numbers: 6.2008.2215
First Posted: December 17, 2009    Key Record Dates
Last Update Posted: February 4, 2015
Last Verified: February 2015

Keywords provided by Stine Marie Ulven, Oslo and Akershus University College of Applied Sciences:
Focus: health effects from omega-3 fatty acids, from fish oil with different quality